Market revenue in 2024 | USD 103.9 million |
Market revenue in 2030 | USD 197.0 million |
Growth rate | 11.3% (CAGR from 2024 to 2030) |
Largest segment | In vitro |
Fastest growing segment | In vitro |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In vitro, In vivo |
Key market players worldwide | Eurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Catalent Inc, Icon PLC, Medpace Holdings Inc, Labcorp Drug Development, Wuxi AppTec Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to toxicity testing outsourcing market will help companies and investors design strategic landscapes.
In vitro was the largest segment with a revenue share of 57.75% in 2024. Horizon Databook has segmented the Australia toxicity testing outsourcing market based on in vitro, in vivo covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia toxicity testing outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Australia toxicity testing outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account